Estimated read time 3 min read

GlaxoSmithKline’s Arexvy vaccine shows promise in protecting adults aged 50-59 against RSV

In a significant development, GlaxoSmithKline (GSK) announced promising results from a late-stage clinical trial for their vaccine, Arexvy, which exhibits the potential to protect adults [more…]

Estimated read time 4 min read

Individuals eager for Covid boosters are not receiving them as intended

The transition of responsibility for distributing Covid-19 vaccines from federal agencies to the commercial market has encountered significant challenges. Many individuals seeking Covid-19 booster shots [more…]

Estimated read time 3 min read

Neuralink poised to commence human trials for a brain implant designed to assist patients suffering from paralysis

Neuralink, the brain-implant startup led by Elon Musk, has announced that an independent review board has granted approval to initiate the recruitment of participants for [more…]